Seres Therapeutics (MCRB) Secures $3.6M in CARB-X Funding for Breakthrough SER-155 Program
Seres Therapeutics, Inc. (NASDAQ:MCRB) is a pioneer in the field of live biotherapeutic products, emerging from the earliest…
Seres Therapeutics (MCRB): The $100M Microbiome Gem Flying Under Wall Street’s Radar
Seres Therapeutics, Inc. (NASDAQ:MCRB) is a pioneering biotechnology company at the forefront of developing microbiome therapeutics—a groundbreaking class…
Could Seres Therapeutics (MRCB) Replace Antibiotics? This Biotech’s Next Drug Could Do It
Seres Therapeutics (MRCB), based in Cambridge, Massachusetts, stands at the vanguard of the live biotherapeutics revolution. Since its…